NUS scientists develop novel chip for fast and accurate disease detection at low cost
(National University of Singapore) A novel invention by a team of researchers from the National University of Singapore holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of Biomedical Engineering at the NUS Faculty of Engineering and his team have developed a tiny microfluidic chip that could effectively detect minute amounts of biomolecules without the need for complex lab equipment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2018 Category: International Medicine & Public Health Source Type: news
Biomedical Engineer Says Her New Smart Socks Can Save The Lives And Limbs Of Diabetics
A biomedical engineer has created a pair of socks that can monitor diabetic feet and prevent amputation. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 28, 2018 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news
Will Your Next Doctor Be a Physicianeer?
All too often in the medical device field, a product that looks really cool ends up failing because it doesn't actually address an unmet need or because the developers didn't do enough collaboration with physicians to make the technology adoptable.
The ever-growing need to have cross-functional teams in medtech led to an interesting panel discussion this week at the South by Southwest conference in Austin, TX.
"As things get more complex you just can't have engineers that don't talk to physicians or don't understand anatomical challenges," said Joseph Frassica, MD, head of Philips Research, Americas and the chief medical ...
Source: MDDI - March 15, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: R & D Source Type: news
Humacyte closes $75m Series C round
Humacyte said today that it raised $75 million in a Series C preferred stock financing, led by a group of existing private investors and new investors.
The Research Triangle Park, N.C.-based company expects to use its newly-acquired funds to support an on-going Phase III pivotal study evaluating its human acellular vessel, Humacyl, as a conduit for hemodialysis in patients with end-stage renal disease who cannot have fistula placement.
Humacyte finished enrolling participants in the 350-patient trial last September and anticipates 12-month post-implantation data to be available in the third quarter of 2018.
The company als...
Source: Mass Device - March 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Funding Roundup Vascular Humacyte Inc. Source Type: news
Retinal images can be used to predict cardiovascular risk
A study inNature Biomedical Engineering reports that using pictures of the retina can be useful to predict cardiovascular risk factors.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 21, 2018 Category: Endocrinology Source Type: news
Deconstructing lupus -- could some of its makeup be part of its cure?
(University of Houston) University of Houston biomedical engineer Chandra Mohan is examining the protein ALCALM to find a cure for lupus and its complications. ALCALM appears in patients that have kidney disease and lupus. Mohan says it's like finding a suspect at the scene of different crimes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2018 Category: International Medicine & Public Health Source Type: news
Student research team accelerates snow melt with 'Melt Mat'
(Virginia Tech) 'The idea for a thermal absorptive blanket is novel, but also very practical,' said Jonathan Boreyko, an assistant professor of biomedical engineering and mechanics and the team's faculty advisor. 'For novelty's sake, the team really needed to go for a journal publication. For practicality's sake, we went for a patent.' (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 15, 2018 Category: Biology Source Type: news
Device that measures cell strength could help identify drugs for asthma, hypertension and muscular dystrophy
Engineers, doctors and scientists at UCLA and Rutgers University have developed a tool that measures the physical strength of individual cells 100 times faster than current technologies.The new device could make it easier and faster to test and evaluate new drugs for diseases associated with abnormal levels of cell strength, including hypertension, asthma and muscular dystrophy. It could also open new avenues for biological research into cell force. It is the first high-throughput tool that can measure the strength of thousands of individual cells at a time.“Our tool tracks how much force individual cells exert over time...
Source: UCLA Newsroom: Health Sciences - February 9, 2018 Category: Universities & Medical Training Source Type: news
This Tiny Implant Can Deliver Medicine to Your Brain With the Push of a Button
(WASHINGTON) — Scientists have created a hair-thin implant that can drip medications deep into the brain by remote control and with pinpoint precision.
Tested only in animals so far, if the device pans out it could mark a new approach to treating brain diseases — potentially reducing side effects by targeting only the hard-to-reach circuits that need care.
“You could deliver things right to where you want, no matter the disease,” said Robert Langer, a professor at the Massachusetts Institute of Technology whose biomedical engineering team reported the research Wednesday.
Stronger and safer treatment...
Source: TIME: Health - January 25, 2018 Category: Consumer Health News Authors: Lauren Neergaard / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news
This Tiny Implant Can Deliver Medicine to Your Brain With the Push of a Button
(WASHINGTON) — Scientists have created a hair-thin implant that can drip medications deep into the brain by remote control and with pinpoint precision.
Tested only in animals so far, if the device pans out it could mark a new approach to treating brain diseases — potentially reducing side effects by targeting only the hard-to-reach circuits that need care.
“You could deliver things right to where you want, no matter the disease,” said Robert Langer, a professor at the Massachusetts Institute of Technology whose biomedical engineering team reported the research Wednesday.
Stronger and safer treatment...
Source: TIME: Science - January 25, 2018 Category: Science Authors: Lauren Neergaard / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news
With these special bacteria, a broccoli a day can keep the cancer doctor away
(National University of Singapore, Yong Loo Lin School of Medicine) NUS Medicine researchers have engineered bacteria that specifically targets colorectal cancer cells and converts a substance in some vegetables into an anticancer agent. The system reduced the number of tumors by 75 percent and shrank the remaining tumors by threefold in a mouse model of colorectal cancer. Published in Nature Biomedical Engineering, the study suggests that the probiotics taken together with a diet rich in cruciferous vegetables could help prevent colorectal cancer and its recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2018 Category: Cancer & Oncology Source Type: news
Uncovering the power of glial cells
(University of Pittsburgh) Implanted devices send targeted electrical stimulation to the nervous system to interfere with abnormal brain activity, and it is commonly assumed that neurons are the only important brain cells that need to be stimulated by these devices. However, research published in Nature Biomedical Engineering reveals that it may also be important to target the supportive glial cells surrounding the neurons. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 8, 2018 Category: Biology Source Type: news
Making heart transplants obsolete with small removable pump
(University of Houston) On this 50th anniversary of the first heart transplant, which occurred in December 1967, a University of Houston biomedical engineer is creating a next-generation heart pump for patients suffering with heart failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2017 Category: International Medicine & Public Health Source Type: news
Wright Medical acquires surgery planning software dev IMASCAP SAS for $89m
Wright Medical (NSDQ:WMGI) said today it inked a deal to acquire shoulder replacement surgery preoperative planning software dev IMASCAP SAS in a deal worth $88.8 million (EU €75.1 million)
Through the deal, Wright picked up 100% of IMASCAP’s outstanding equity on a fully diluted basis for a total of $88.8 million, consisting of $46.9 million (EU €39.7 million) in cash and $15.6 million (EU €13.2 million) of Wright shares, payable at closing, and $26.3 million (EU €22.2 million) in potential milestone or earn out payments.
“Wright, and previously Tornier, has been involved with IMASCAP for many years ...
Source: Mass Device - December 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Orthopedics Software / IT Surgical imascapsas wrightmedical Source Type: news
